Toxic Coldrif Syrup Kills Children
Analysis based on 7 articles · First reported Oct 05, 2025 · Last updated Oct 05, 2025
The event has a significant negative impact on the pharmaceutical market, particularly for private companies like Sresan Pharmaceuticals, whose products have been banned and are under investigation. It also raises concerns about drug quality control and regulatory oversight in India, potentially leading to stricter regulations and increased scrutiny across the industry.
A tragic event unfolded in India — Madhya Pradesh, India, where at least 18 children, mostly under five years old, died from acute kidney failure after consuming contaminated Coldrif syrup cough syrup. Dr. Praveen Soni, a government pediatrician, was arrested and suspended for prescribing the syrup, which was found to contain lethal levels (48.6%) of diethylene glycol, a toxic industrial chemical. Sresan Pharmaceuticals, the India — Tamil Nadu-based manufacturer of Coldrif syrup, has been booked under various sections of the Bharatiya Nyaya Sanhita and the Drugs and Cosmetics Act. The India — Madhya Pradesh government has banned the sale and distribution of Coldrif syrup and all other products from Sresan Pharmaceuticals, offering Rs 4 lakh compensation to the victims' families. The India — Central Drugs Standard Control Organisation has initiated risk-based inspections of drug manufacturing units across six states, highlighting a nationwide concern over drug safety.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard